Bio-Hermes
Global Healthcare Magazine: Building Healthcare Companies With Purpose and Precision
Long before Alzheimer’s disease became a global crisis, it was already shaping quiet, devastating stories inside individual families. Science was fragmented. Treatments were elusive. And for decades, progress moved more slowly than anyone anticipated. For entrepreneurs working in healthcare, the challenge was not just scientific. It was structural. How do you build companies that can […]
Nature: Blood tests for Alzheimer’s disease could reshape research and care
This Nature article highlights how blood-based biomarkers for Alzheimer’s disease stand to have the potential to transform diagnostics, and how new treatments and therapies are developed. There is mention of how Bio-Hermes-001, and Bio-Hermes-002, use head-to-head comparisons of blood-based biomarkers and digital tests to explore which combinations of blood-based biomarkers perform best across different populations and […]
GAP Statement on “Interchangeability of blood-based biomarkers and PET to identify Alzheimer’s disease pathology”
“Changes in memory and cognitive health can start decades before symptoms appear. That’s why early diagnosis and intervention are crucial to slowing impact. A new paper co-authored by GAP with our partners at Eli Lilly and Company, “Interchangeability of blood-based biomarkers and PET to identify Alzheimer’s disease Pathology” published in Alzheimer’s & Dementia shows that blood biomarkers (P-tau 217 and Precivity AD) have high agreement with […]
GAP Statement on Recent Bio-Hermes-001 Publication in Alzheimer’s & Dementia
“We’re pleased and proud to report our latest paper using Bio-Hermes-001 data has been published in Alzheimer’s & Dementia. Many thanks to the co-authors who helped to bring this research article to light including Richard Mohs, Douglas Beauregard, Lynne Hughes, Cyndy Cordell, Allan Levey, M.D., Ph.D., Saima Rathore, Nicholas Seyfried, Erik Johnson, Jessie Nicodemus-Johnson, Joshua Christensen, and Robin […]
Neurology Advisor: CTAD 2025: Highlights in Alzheimer Disease Research
Tori Rodriguez, MA, LPC, AHC Publish DateJanuary 27, 202 At the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held December 1 to 4, 2025, in San Diego, California, researchers presented new data spanning observational studies, biomarker analyses, and clinical development programs in Alzheimer disease (AD). Key topics included emerging evidence on metabolic therapies such as […]
The Independent: The finger prick blood test that could revolutionise Alzheimer’s diagnosis
The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies
Washington D.C., Jan 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of clinical […]
WPBF: ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings
20 Dec ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings Posted at 20:23h in Uncategorized by Belinda Russell 0 Comments ATLANTIS, Fla. — It’s the holiday season and while you celebrate with friends and family some experts say you may also notice some changes in elderly loved ones you haven’t seen for a while. Dr. Linda […]
Think Global Health: A New Era for Alzheimer’s Disease Diagnosis
Aging Emerging biomarkers and digital tools are unlocking earlier and more accurate diagnosis Teresa, 75, an Alzheimer’s patient and former businesswoman, poses for a photograph inside the Alzheimer Foundation, in Mexico City, Mexico, on April 19, 2012.REUTERS/Edgard Garrido by Lydia Wu, Jennifer Panlilio, Melissa Lee, Laura Nisenbaum, Aishu Sukumar December 10, 2025 Alzheimer’s disease and related dementias affect more than […]
WMNF: Tampa plays role in study detecting early Alzheimer’s
Posted on October 2, 2025 • by Julia Ferrar Most biomarker tests, such as PET scans and spinal taps, are expensive or invasive and can pose risks for patients. That’s why a company in the Tampa Bay area is helping to research blood tests for biomarkers as a less expensive and more accessible alternative. Axiom […]